Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivo

Clinica Chimica Acta

Volumn 288, Issue 1-2, 1999, Pages 21-30

  Kostner, Karam ^a   Banyai, Susanne ^a   Jansen, Martin ^a   Khoschsorur, Gholamali ^b   Hörl, Walter H ^a   Maurer, Gerald ^a   Winklhofer Roob, Brigitte ^b   Derfler, Kurt ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Atherosclerosis; Extracorporeal treatment; Hypercholesterolemia; LDL apheresis; Lipid peroxidation; TBARS

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CHOLESTEROL; FATTY ACID; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PROBUCOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; APHERESIS; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ADULT; BLOOD COMPONENT REMOVAL; CASE-CONTROL STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0032872053     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00087-X     Document Type: Article

References (26)

1. Kostner KM. Radical therapy of refractory hyperlipidaemia: Extracorporeal cholesterol elimination. Wien Med Wochensch 1994;12-13:333-5.
2. Stoffel W, Greve V, Borberg H. Application of specific extracorporeal removal of LDL in familial hypercholesterolaemia. Lancet 1981;1:1005-7.
3. Parthasarathy S, Steinberg D, Witzum JL. The role of oxidized LDL in the pathogenesis of atherosclerosis. Annu Rev Med 1992;43:219-25.
4. Leake DS. Oxidized low density lipoproteins and atherosclerosis. Br Heart J 1993;69:476-8.
5. Witzum JL. Role of oxidized low density lipoproteins in atherogenesis. Br Heart J 1993;69:12-8.
6. Berliner JA, Haberland ME. The role of oxidized LDL in atherogenesis. Curr Opin Lipidol 1993;1:373-81.
7. Dasgupta A, Hussain S, Ahmad S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 1992;60:56-9.
8. Descamps-Latscha B, Goldfarb B, Nguyen AT. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialysed patients. A randomized prospective study. Nephron 1991;59:279-85.
9. Elstner EF. Oxygen radicals. Biochemical basis for their efficacy. Klin Wochenschr 1991;69:949-56.
10. Salmon S, Maziere J, Morliere P, Bouchemal N. UVB-induced photooxidation of lipids of human low and high density lipoproteins. A possible role of tryptophan residues. Photochem Photobiol 1990;52:541-5.
11. Chajes V, Sattler W, Stultschnig M, Kostner G. Photometric evaluation of lipid hydroperoxides in human plasma: Correlation with different oxidation parameters. Atherosclerosis 1996;121:193-203.
12. Tateishi T, Yoshimine N, Kuzuya F. Serum lipid measurement by a new colorimetric method. Exp Ger 1987;22:103-6.
13. Esterbauer H, Cheesman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydoxynonenal. Methods Enzymol 1990;186:407-21.
14. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987;33:214-20.
15. Rabel H, Khoschsorur G, Colombo T, Tatzber F, Esterbauer H. Human plasma lipid peroxide levels show a strong transient increase after successful revascularization operations. Free Radic Biol Med 1992;13:281-8.
16. Winklhofer-Roob B, Puhl H, Khoschsorur G, Esterbauer H, Shmerling DH. Enhanced resistance to oxidation of LDL in cystic fibrosis. Free Radic Biol Med 1995;18:849-59.
17. Steyrer E, Durovic S, Frank S, Giessauf W, Burger A, Dieplinger H, Zechner R, Kostner GM. The role of lecithin: cholesterol acyltransferase for lipoprotein(a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma. J Clin Invest 1994;94:2330-40.
18. Borberg H, Gaczkowski A, Hombach V, Oette K, Stoffel W. Treatment of familial hypercholesterolemia by means of specific immunoadsorption. J Clin Apheresis 1988;4:459-66.
19. Borberg H, Kadar J, Oette K. The current status of LDL Apheresis. Curr Stud Hematol Blood Trans 1990;57:239-48.
20. Armstrong VW, Niedmann D, Eisenhauer T. Acute and long term effects of low density lipoprotein apheresis on serum concentration of vitamins E and A. Klin Wochenschrift 1988;66:123-9.
21. Assogba U, Lepage S, Bruckert E, Bonnefont-Rousselot D, Dairou F, DeGennes JL, Delattre J. Blood antioxidants (vitamin E and β-carotene) in long term low density lipoprotein apheresis. Clin Chim Acta 1995;235:147-57.
22. Descamps-Latscha B, Goldfarb B, Nguyen AT. Establishing the relationship between complement activation and stimulation of phagozyte oxidative metabolism in hemodialysed patients. A randomized prospective study. Nephron 1991;59:279-85.
23. Peuchant E, Carbonneau M, Dubourg L, Thomas M, Perromat A, Vallot C, Clerc M. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: Vitamin A, E and iron status. Free Radic Biol Med 1994;16:339-46.
24. Jackson P, Loughrey C, Lightbody JH, McNamee PT, Young I. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995;41:1135-8.
25. Wieland E, Schettler V, Creutzfeld C, Kickbush H, Schuff-Werner P. Lack of plasma lipid peroxidation during LDL-apheresis by HELP LDL-precipitation. Eur J Clin Invest 1995;25:838-42.
26. Leitinger N, Pirich C, Blazek I, Endler G, Sinzinger H. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment. Atherosclerosis 1996;126:305-12.